Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01656967 · ClinicalTrials.gov registry record · NA
AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01656967 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 66 participants.
The verdict
NCT01656967, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two types of supraglottic airways (SGA), the Ambu® Aura-I and the Intubating Laryngeal Mask Airway (ILMA), regarding time to intubate, ease of insertion, sealing properties, optical view upon fiberoptic examination regarding the Ambu Aura-I, ease and success rate of intubation, airway morbidity, and patient comfort in patients undergoing general anesthesia for elective surgery.
Interventions
- DEVICE AMBU Aura-I/aScope 2
- DEVICE LMA Fastrach Single Use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-07 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01656967
The ClinicalTrials.gov registry entry for NCT01656967 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AMBU Aura-I/aScope 2 is the first listed.
NCT01656967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01656967 about?
NCT01656967 is a clinical study titled "AMBU AScope2 Fiberoptic Intubation Versus Fastrach Intubating LMA". The purpose of this study is to compare two types of supraglottic airways (SGA), the Ambu® Aura-I and the Intubating Laryngeal Mask Airway (ILMA), regarding time to intubate, ease of insertion, sealing properties, optical view upon fiberoptic examination regarding the Ambu Aura-I, ease and success r...
What is the current status of trial NCT01656967?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2010-07. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01656967?
The interventions under investigation include: AMBU Aura-I/aScope 2 (DEVICE), LMA Fastrach Single Use (DEVICE).
Who is sponsoring clinical trial NCT01656967?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.